Whittier Trust Co. Sells 4,352 Shares of CVS Health Corporation (NYSE:CVS)

Whittier Trust Co. lowered its stake in CVS Health Corporation (NYSE:CVS - Free Report) by 25.1% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 12,991 shares of the pharmacy operator's stock after selling 4,352 shares during the quarter. Whittier Trust Co.'s holdings in CVS Health were worth $880,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Cornercap Investment Counsel Inc. bought a new position in CVS Health during the 1st quarter worth $2,011,000. Sumitomo Life Insurance Co. lifted its position in shares of CVS Health by 1.0% during the 1st quarter. Sumitomo Life Insurance Co. now owns 17,114 shares of the pharmacy operator's stock worth $1,159,000 after buying an additional 174 shares in the last quarter. Apollon Wealth Management LLC lifted its position in shares of CVS Health by 5.1% during the 1st quarter. Apollon Wealth Management LLC now owns 35,081 shares of the pharmacy operator's stock worth $2,377,000 after buying an additional 1,717 shares in the last quarter. Catalyst Financial Partners LLC purchased a new stake in shares of CVS Health during the 1st quarter worth approximately $322,000. Finally, Signaturefd LLC grew its stake in CVS Health by 43.6% in the 1st quarter. Signaturefd LLC now owns 19,923 shares of the pharmacy operator's stock valued at $1,350,000 after buying an additional 6,048 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

Insider Activity at CVS Health

In related news, Director Guy P. Sansone bought 1,570 shares of the business's stock in a transaction on Thursday, June 5th. The shares were purchased at an average price of $63.70 per share, with a total value of $100,009.00. Following the completion of the purchase, the director owned 12,007 shares of the company's stock, valued at $764,845.90. This represents a 15.04% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 1.22% of the company's stock.

CVS Health Price Performance

NYSE:CVS opened at $63.34 on Friday. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 0.77. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $72.51. The firm has a market cap of $80.13 billion, a P/E ratio of 15.12, a PEG ratio of 0.91 and a beta of 0.57. The business's 50-day moving average price is $64.80 and its 200 day moving average price is $62.76.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The company had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. During the same period last year, the business earned $1.31 EPS. The business's quarterly revenue was up 7.0% on a year-over-year basis. As a group, sell-side analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Tuesday, July 22nd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.20%. The ex-dividend date is Tuesday, July 22nd. CVS Health's dividend payout ratio is 63.48%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Jefferies Financial Group boosted their price target on shares of CVS Health from $74.00 to $80.00 and gave the stock a "buy" rating in a research note on Monday, June 30th. Truist Financial raised their target price on shares of CVS Health from $82.00 to $84.00 and gave the stock a "buy" rating in a report on Monday, May 12th. Robert W. Baird raised their price objective on shares of CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a research report on Tuesday, April 15th. Mizuho lifted their price target on shares of CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Finally, Wells Fargo & Company reaffirmed an "overweight" rating and set a $84.00 price target (up from $76.00) on shares of CVS Health in a research note on Tuesday, May 6th. Two research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, CVS Health has an average rating of "Moderate Buy" and a consensus target price of $75.06.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.